Inversago Pharma Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Inversago Pharma's estimated annual revenue is currently $2.3M per year.(i)
  • Inversago Pharma's estimated revenue per employee is $100,500

Employee Data

  • Inversago Pharma has 23 Employees.(i)
  • Inversago Pharma grew their employee count by -12% last year.

Inversago Pharma's People

NameTitleEmail/Phone
1
Office Administrator | Executive Assistant to the President & CEOReveal Email/Phone
2
CFOReveal Email/Phone
3
VP Clinical OperationsReveal Email/Phone
4
Head ChemistryReveal Email/Phone
5
VP, Finance and AdministrationReveal Email/Phone
6
VP, Clinical OperationsReveal Email/Phone
7
VP Pharmacology and PKReveal Email/Phone
8
Head ChemistryReveal Email/Phone
9
Associate DirectorReveal Email/Phone
10
Senior Director Preclinical DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.2M11-27%N/AN/A
#2
$30.2M88-29%N/AN/A
#3
N/A1550%N/AN/A
#4
$10.7M1005%$39.7MN/A
#5
$104.3M22845%N/AN/A
#6
$47.8M238N/AN/AN/A
#7
$15.5M775%N/AN/A
#8
$395.8M19697%N/AN/A
#9
$187.3M8318%N/AN/A
#10
$361.6M17996%N/AN/A
Add Company

What Is Inversago Pharma?

Located in Montreal, Inversago Pharma is a privately-owned Canadian biotech company at clinical-stage, specialized in the development of new therapies focusing on CB1 blockade, based on first-in-class, peripherally-acting, CB1 inverse agonists. The Company aims to provide new treatment options that improve the lives of patients affected by metabolic conditions such as diabetic nephropathy, Non-Alcoholic Steatohepatitis (NASH), complications of obesity, hypertriglyceridemia (HTG) and Type 1 Diabetes (T1D), Prader-Willi Syndrome (PWS), as well as fibrotic indications such as Progressive Fibrosis – Interstitial Lung Disease (PF-ILD), including Idiopathic Pulmonary Fibrosis (IPF).

keywords:N/A

N/A

Total Funding

23

Number of Employees

$2.3M

Revenue (est)

-12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.7M23-12%N/A
#2
$2.4M2321%N/A
#3
$2.3M23N/AN/A
#4
$2.3M23N/AN/A
#5
$2.3M23N/AN/A